Characterization of Streptococcus pneumoniae invasive serotype 19A isolates recovered in Colombia

Vaccine

Volumn 32, Issue 7, 2014, Pages 755-758

  Ramos, Viviana ^a   Parra, Eliana L ^a   Duarte, Carolina ^a   Moreno, Jaime ^a  

^a INSTITUTO NACIONAL DE SALUD   (Colombia)

Author keywords

Clonal complexes; Multidrug resistance; Streptococcus pneumoniae serotype 19A isolates

Indexed keywords

CEFTRIAXONE; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; TETRACYCLINE; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CLONE; COLOMBIA; GENE SEQUENCE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MENINGITIS; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR PHYLOGENY; MULTILOCUS SEQUENCE TYPING; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SCHOOL CHILD; SEROTYPE; SPAIN; STREPTOCOCCUS PNEUMONIAE; VERY ELDERLY; YOUNG ADULT;

CLONAL COMPLEXES; MULTIDRUG RESISTANCE; STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A ISOLATES;

COLOMBIA; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 84892849517     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.12.024     Document Type: Article

References (25)

1. O'Brien K.L., Wolfson L.J., Watt J.P., Henkle E., Deloria-Knoll M., McCall N., et al. Hib and pneumococcal global burden of disease study team burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009, 374:893-902.
2. Gil-Prieto R., García-García L., Alvaro-Meca A., Méndez C., García A., de Miguel A.G. The burden of hospitalizations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003-2007). Vaccine 2011, 29:412-416.
3. Weil-Olivier C., van der Linden M., de Schutter I., Dagan R., Mantovani L. Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective. BMC Infect Dis 2012, 12:207. 10.1186/1471-2334-12-207.
4. Tan T.Q. Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines. Clin Microbiol Rev 2012, 25:409-419.
5. Kaplan S.L., Barson W.J., Lin P.L., Stovall S.H., Bradley J.S., Tan T.Q., et al. Serotype 19A is the most common serotype causing invasive pneumococcal infections in children. Pediatrics 2010, 125:429-436.
6. Reinert R., Jacobs M.R., Kaplan S.L. Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development. Vaccine 2010, 28:4249-4259.
7. Pillai D.R., Shahinas D., Buzina A., Pollock R.A., Lau R., Khairnar K., et al. Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae. BMC Genomics 2009, 30(10):642. 10.1186/1471-2164-10-642.
8. Moore M.R., Gertz R.E., Woodbury R.L., Barkocy-Gallagher G.A., Schaffner W., Lexau C., et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States (2005). J Infect Dis 2008, 197:1016-1027.
9. Beall B.W., Gertz R.E., Hulkower R.L., Whitney C.G., Moore M.R., Brueggemann A.B. Shifting genetic structure of invasive serotype 19A pneumococci in the United States. J Infect Dis 2011, 203:1360-1368.
10. Di Fabio J.L., Castañeda E., Agudelo C.I., de la Hoz F., Hortal M., et al. Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigía group 1993-1999. Pediatr Infect Dis J 2001, 20:959-967.
11. CLSI Performance standards for antimicrobial susceptibility testing 2011, Clinical Laboratory Standards Institute, Wayne, PA, CLSI document M100-S21. Twenty-first informational supplement.
12. Vela M.C., Fonseca N., Di Fabio J.L., Castañeda E., et al. Presence of international multiresistant clones of Streptococcus pneumoniae in Colombia. Microb Drug Resist 2001, 7:153-164.
13. Enright M., Spratt B.G. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 1998, 144:3049-3060.
14. Ministerio de Salud y Protección Social. Jornada de Vacunación en Las Américas 2012. http://www.minsalud.gov.co/Lineamientos/Documento_Marco_Jornada_de_Vacunacion_de_las_Am%C3%A9ricas_abril2012.pdf. Accessed June 19, 2013.
15. Xue L., Yao K.H., Yu S.J., Liu Z.J., Qian J., Shen X.Z., Yang Y.H. Molecular epidemiology of serotype 19A Streptococcus pneumoniae isolated from children in Beijing, 1997-2006. Chin Med J 2011, 124:1769-1774.
16. Shin J., Baek J.Y., Kim S.H., Song J.H., Ko K.S. Predominance of ST320 among Streptococcus pneumoniae serotype 19A isolates from 10 Asian countries. J Antimicrob Chemother 2011, 66:1001-1004.
17. Marimón J.M., Alonso M., Rolo D., Ardanuy C., Liñares J., Pérez-Trallero E. Molecular characterization of Streptococcus pneumoniae invasive serotype 19A isolates from adults in two Spanish regions (1994-2009). Eur J Clin Microbiol Infect Dis 2012, 31:1009-1013.
18. Kim S.H., Song J.H., Chung D.R., Thamlikitkul V., Yang Y., Wang H., et al. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Antimicrob Agents Chemother 2012, 56:1418-1426.
19. Shi Z.Y., Enright M.C., Wilkinson P., Griffiths D., Spratt B.G. Identification of three major clones of multiply antibiotic-resistant Streptococcus pneumoniae in Taiwanese hospitals by multilocus sequence typing. J Clin Microbiol 1998, 36:3514-3519.
20. Ardanuy C., Rolo D., Fenoll A., Tarrago D., Calatayud L., Liñares J. Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain. J Antimicrob Chemother 2009, 64:507-510.
21. Mahjoub-Messai F., Doit C., Koeck J.L., Billard T., Evrard B., Bidet P., et al. Population snapshot of Streptococcus pneumoniae serotype 19A isolates before and after introduction of seven-valent pneumococcal vaccination for French children. J Clin Microbiol 2009, 47:837-840.
22. Wyres K.L., Lambertsen L.M., Croucher N.J., McGee L., von Gottberg A., Liñares J., et al. Pneumococcal capsular switching: a historical perspective. J Infect Dis 2013, 207:439-449.
23. Song J.H., Dagan R., Klugman K.P., Fritzell B. The relationship between pneumococcal serotypes and antibiotic resistance. Vaccine 2012, 30:2728-2737.
24. Instituto Nacional de Salud (CO). Serotipos y patrones de susceptibilidad antimicrobiana de patógenos de importancia en salud pública. Bogotá: INS; 2012. Available from: http://www.ins.gov.co/tramites-y-servicios/examenes-de-intere´s-en-salud-publica/Microbiologa/microbiologia%20spn%202012.pdf. Accessed 15 June 2013.
25. Pai R., Moore M.R., Pilishvili T., Gertz R.E., Whitney C.G., Beall B. Active bacterial core surveillance team. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis 2005, 192:1988-1995.